au.\*:("MIZUSHIMA, Yutaka")
Results 1 to 25 of 29
Selection :
Lipid microspheresMIZUSHIMA, Yutaka.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, issn 0169-409X, 156 p.Serial Issue
Application of lipid microspheres for the treatment of cancerTAKENAGA, M.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, pp 209-219, issn 0169-409XArticle
Approved indications of lipo-PGE1 in JapanHOSHI, K.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, pp 171-176, issn 0169-409XArticle
Lipo-NSAID preparationOHMUKAI, O.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, pp 203-207, issn 0169-409XArticle
Limethason as a lipid microsphere preparation : An overviewYOKOYAMA, K; WATANABE, M.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, pp 195-201, issn 0169-409XArticle
Efficient encapsulation of a water-soluble corticosteroid in biodegradable nanoparticlesISHIHARA, Tsutomu; TAKAHASHI, Miyuki; HIGAKI, Megumu et al.International journal of pharmaceutics (Print). 2009, Vol 365, Num 1-2, pp 200-205, issn 0378-5173, 6 p.Article
Drug delivery system to control infectious diseasesSHOJI, Yoko; SHIMADA, Jingoro; MIZUSHIMA, Yutaka et al.Current pharmaceutical design. 2002, Vol 8, Num 6, pp 455-465, issn 1381-6128Article
Liposomes in gene therapyLASIC, D. D; TEMPLETON, N. S.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, pp 221-266, issn 0169-409XArticle
Distribution of lipid microsphere preparationsIGARASHI, R; TAKENAGA, M; MATSUDA, T et al.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, pp 147-154, issn 0169-409XArticle
New lipo-PGE1 using a stable prodrug of prostaglandin E1 (PGE1)IGARASHI, R; MIZUSHIMA, Y.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, pp 189-194, issn 0169-409XArticle
Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agentsISHIHARA, Tsutomu; TAKAHASHI, Miyuki; HIGAKI, Megumu et al.International journal of pharmaceutics (Print). 2010, Vol 385, Num 1-2, pp 170-175, issn 0378-5173, 6 p.Article
Effect of Choto-san, a Kampo medicine, on impairment of passive avoidance performance in senescence accelerated mouse (SAM)MIZUSHIMA, Yutaka; KAN, Shin; YOSHIDA, Satoshi et al.PTR. Phytotherapy research. 2003, Vol 17, Num 5, pp 542-545, issn 0951-418X, 4 p.Article
Efficient Entrapment of Poorly Water-Soluble Pharmaceuticals in Hybrid NanoparticlesISHIHARA, Tsutomu; GOTO, Maoko; KANAZAWA, Hideko et al.Journal of pharmaceutical sciences. 2009, Vol 98, Num 7, pp 2357-2363, issn 0022-3549, 7 p.Article
Lipid microsphere preparation of a prostacyclin analogueKUROZUMI, S; ARAKI, H; TANABE, H et al.Advanced drug delivery reviews. 1996, Vol 20, Num 2-3, pp 181-187, issn 0169-409XArticle
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticlesISHIHARA, Tsutomu; TAKEDA, Miho; MAEDA, Taishi et al.Pharmaceutical research. 2009, Vol 26, Num 10, pp 2270-2279, issn 0724-8741, 10 p.Article
Prolonging the In Vivo Residence Time of Prostaglandin E1with Biodegradable NanoparticlesISHIHARA, Tsutomu; TAKAHASHI, Miyuki; HIGAKI, Megumu et al.Pharmaceutical research. 2008, Vol 25, Num 7, pp 1686-1695, issn 0724-8741, 10 p.Article
Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugsMIZUSHIMA, Yutaka; IKOMA, Toshiyuki; TANAKA, Jyunzo et al.Journal of controlled release. 2006, Vol 110, Num 2, pp 260-265, issn 0168-3659, 6 p.Article
Drug delivery to the cochlea using PLGA nanoparticlesTAMURA, Tetsuya; KITA, Tomoko; NAKAGAWA, Takayuki et al.The Laryngoscope. 2005, Vol 115, Num 11, pp 2000-2005, issn 0023-852X, 6 p.Article
Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosisTANAKA, Ken-Ichiro; ISHIHARA, Tomoaki; SATO, Keizo et al.American journal of physiology. Lung cellular and molecular physiology. 2010, Vol 42, Num 3, issn 1040-0605, L348-L360Article
Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic PolymersISHIHARA, Tsutomu; MAEDA, Taishi; SAKAMOTO, Haruka et al.Biomacromolecules. 2010, Vol 11, Num 10, pp 2700-2706, issn 1525-7797, 7 p.Article
Synthesis of Prostaglandin E1 Phosphate Derivatives and Their Encapsulation in Biodegradable NanoparticlesTAKEDA, Miho; MAEDA, Taishi; IGARASHI, Rie et al.Pharmaceutical research. 2009, Vol 26, Num 7, pp 1792-1800, issn 0724-8741, 9 p.Article
Optimum formulation for sustained-release insulinTAKENAGA, Mitsuko; YAMAGUCHI, Yoko; KITAGAWA, Aki et al.International journal of pharmaceutics. 2004, Vol 271, Num 1-2, pp 85-94, issn 0378-5173, 10 p.Article
Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoidHIGAKI, Megumu; AZECHI, Yasutaka; TAKASE, Tsugiko et al.Vaccine. 2001, Vol 19, Num 23-24, pp 3091-3096, issn 0264-410XArticle
Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profileISHIHARA, Tsutomu; IZUMO, Nobuo; HIGAKI, Megumu et al.Journal of controlled release. 2005, Vol 105, Num 1-2, pp 68-76, issn 0168-3659, 9 p.Article
Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its releaseCHINEN, Naofumi; TANIHARA, Masao; NAKAGAWA, Miyako et al.Journal of biomedical materials research. 2003, Vol 67A, Num 1, pp 61-68, issn 0021-9304, 8 p.Article